Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it ...

Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps ...

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors. Cell therapies, which have primarily made waves in the treatment of patients with blood ...

Lung cancer is often misunderstood, leading to delayed diagnosis and missed treatment opportunities. Experts debunk myths ...

Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.

Neoadjuvant chemoimmunotherapy demonstrated high pathological response rates with “manageable” toxicity in patients with squamous cell lung cancer, according to data presented at European Lung Cancer ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...